Research & Education

E-Cigarettes: Friend or Foe?

Wednesday, April 1, 2015 - Recording Available
 Maciej Goniewicz  Ben Toll  Matthen Steliga

Maciej Goniewicz, PhD
Department of Health Behavior
Division of Cancer Prevention
and Population Studies
Roswell Park Cancer Institute
Co-author of the ASCO/AACR
statement on electronic cigarettes
Buffalo, NY

Ben Toll, PhD
Associate Professor of Public Health Sciences
Chief of Tobacco Cessation
and Health Behaviors
Medical University of South Carolina
Co-author of the ASCO/AACR
statement on electronic cigarettes

Matthew Steliga, MD
Associate Professor
Department of Surgery-Thoracic Oncology
WP Rockefeller Cancer Institute
University of Arkansas
Little Rock, Arkansas USA

Name of Reviewer(s): 

              

Fred Hirsch, MD, PhD –Speakers Bureau/Advisory Board: Astrazeneca, Genentech, BMS, Lilly and Abbvie.

Name of Planner(s): 

 

     Deb Whippen-Nothing to Disclose

Name of Activity: 

 

E-Cigarettes: Friend or Foe?

Date of Activity:

 

04/01/2015

Faculty/Speaker(s):

 

Maciej Goniewicz, PhD- Speaker- Received a Research grant from Pfizer.

Ben Toll, PhD- Speaker- Received research grant from Pfizer.

Matthew Steliga, MD- Moderaror- Nothing to Disclose

Type of Activity: 

 Live Course

  Internet Live Course (Webinar)XXXX

 Internet Enduring Material

Are there Commercial Supporters for this activity?

     No

If yes, please list:

IASLC presents part two of this Smoking Cessation and Tobacco Control LIVE webinar series. This program will:

  • Present an objective look at electronic cigarettes
  • Educate the audience about the different types of e-cigarettes
  • Examine the evidence regarding the safety and efficacy of e-cigarettes for smoking cessation
  • Provide data on use of e-cigarettes including use by cancer patients
  • Discuss how to address questions from your cancer patients about the use of e-cigarettes and what advice can be given

Following the presentation, there will be ample time for discussion and questions with Dr. Matthew Steliga as the moderator. Attendees will be able to submit questions and comments to the faculty via Internet chat.

After attending this program participants will:

    • Determine what e-cigarettes are, how they are made, and who is selling them
    • Describe the current evidence on the safety and efficacy of e-cigarettes for smoking cessation
    • Describe current data on the use of e-cigarettes, by youth, adults, and cancer patients
    • Evaluate how to respond to questions you might get from patients who are using e-cigarettes 

CME INFO:

Financial/Commercial Relationships DISCLOSURES

A Conflict of Interest (COI) is created and exists when individuals in a position to control the content of CME, or their spouses/partners, that have a relevant personal financial relationship within the past 12 months with a commercial interest that produces, markets, re-sells, or distributes health care goods or services consumed by, or used, on patients that benefits the individual in any financial amount and therefore, may bias their opinions and teachings. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or any other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research and clinical trials), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities for which remuneration is received or expected. 

 This IASLC CME educational activity was planned and developed to: uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and, include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.

IASLC CME assures that the planners/reviewers/authors/faculty/moderators/peer reviewers et. al. conflicts of interest  were identified, reviewed and resolved from all individuals involved in the development  or able to influence and control the content of this CME activity; IASLC CME assures that disclosure is given prior to an educational activity being delivered to learners.  Any individual who failed or refused to disclose relevant financial relationships was disqualified from this CME activity and removed from any of IASLC CME activity presentation.

All commercial relationships and conflicts of interest that are identified are thoroughly vetted by IASLC Ethics Committee, CME Subcommittee, and Independent reviewer. COI will be evaluated by the Board of Directors of the IASLC for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. IASLC CME is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial entity.

 

CREDIT STATEMENT

IASLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

IASLC CME designates this Internet Live Course activity for a maximum of 1 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

GOAL & PURPOSE

The objective of this workshop is:

  • Present an objective look at electronic cigarettes
  • Educate the audience about the different types of e-cigarettes
  • Examine the evidence regarding the safety and efficacy of e-cigarettes for smoking cessation
  • Provide data on use of e-cigarettes including use by cancer patients
  • Discuss how to address questions from your cancer patients about the use of e-cigarettes and what advice can be given

TARGET AUDIENCE

This CME live webinar series is designed to meet the educational needs of healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists and advanced practice nurses and physicians' assistants.

DISCLAMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Thank you for your participation.

IASLC Financial/Commercial Relationships and Conflicts of Interest Policy

IASLC Honoraria Policy

IASLC Commercial Support Agreement (LOA)

If you are interested in obtaining the CME Credits for these sessions you must indicate this when you register for the program. CME credit is only available to attendees of the live webinar.

DOWNLOAD RECORDING

Location Local time Time zone UTC offset
New York (U.S.A. - New York) Wednesday, April 1, 2015 at 7:00:00 PM EDT UTC-4 hours
Denver (U.S.A. - Colorado) Wednesday, April 1, 2015 at 5:00:00 PM MDT UTC-6 hours
Chicago (U.S.A. - Illinois) Wednesday, April 1, 2015 at 6:00:00 PM CDT UTC-5 hours
Los Angeles (U.S.A. - California) Wednesday, April 1, 2015 at 4:00:00 PM PDT UTC-7 hours
São Paulo (Brazil - São Paulo) Wednesday, April 1, 2015 at 8:00:00 PM BRT UTC-3 hours
Paris (France) Thursday, April 2, 2015 at 1:00:00 AM CEST UTC+2 hours
Hong Kong (Hong Kong) Thursday, April 2, 2015 at 7:00:00 AM HKT UTC+8 hours
Tokyo (Japan) Thursday, April 2, 2015 at 8:00:00 AM JST UTC+9 hours
London (United Kingdom - England) Midnight between Wednesday, April 1, 2015 and Thursday, April 2, 2015 BST UTC+1 hour
Corresponding UTC (GMT) Wednesday, April 1, 2015 at 23:00:00    

How to use the Time Zone Converter